Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Siwek A

No contact information in database for Siwek A

    Title: Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity-Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease
    Wieckowski K, Szalaj N, Gryzlo B, Wichur T, Goral I, Slugocka E, Sniecikowska J, Latacz G, Siwek A and Wieckowska A <3 more author(s)>
    Ref: Int J Mol Sci, 23:, 2022 : PubMed


    Title: Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations
    Sari S, Barut B, Marcinkowska M, Sabuncuoglu S, Avci A, Kocak Aslan E, Ozel A, Siwek A
    Ref: Drug Dev Res, :, 2021 : PubMed


    Title: Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT(6) receptor with anti-aggregation properties against amyloid-beta and tau
    Wichur T, Pasieka A, Godyn J, Panek D, Goral I, Latacz G, Honkisz-Orzechowska E, Bucki A, Siwek A and Wieckowska A <7 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 225:113783, 2021 : PubMed


    Title: Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with beta-amyloid anti-aggregation properties
    Wichur T, Godyn J, Goral I, Latacz G, Bucki A, Siwek A, Gluch-Lutwin M, Mordyl B, Sniecikowska J and Wieckowska A <8 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 225:113792, 2021 : PubMed


    Title: Rational design of new multitarget histamine H(3) receptor ligands as potential candidates for treatment of Alzheimer's disease
    Lazewska D, Bajda M, Kaleta M, Zareba P, Doroz-Plonka A, Siwek A, Alachkar A, Mogilski S, Saad A and Kiec-Kononowicz K <11 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 207:112743, 2020 : PubMed


    Title: New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
    Malek R, Arribas RL, Palomino-Antolin A, Totoson P, Demougeot C, Kobrlova T, Soukup O, Iriepa I, Moraleda I and Ismaili L <12 more author(s)>
    Ref: Journal of Medicinal Chemistry, 62:11416, 2019 : PubMed


    Title: Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity
    Marcinkowska M, Bucki A, Panek D, Siwek A, Fajkis N, Bednarski M, Zygmunt M, Godyn J, Del Rio Valdivieso A and Wieckowska A <2 more author(s)>
    Ref: Arch Pharm (Weinheim), :e1900041, 2019 : PubMed


    Title: Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease
    Wieckowska A, Wichur T, Godyn J, Bucki A, Marcinkowska M, Siwek A, Wieckowski K, Zareba P, Knez D and Malawska B <10 more author(s)>
    Ref: ACS Chem Neurosci, 9:1195, 2018 : PubMed


    Title: Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation
    Wieckowska A, Kolaczkowski M, Bucki A, Godyn J, Marcinkowska M, Wieckowski K, Zareba P, Siwek A, Kazek G and Malawska B <7 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 124:63, 2016 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer